Global Hemp Group Stock Price, News & Analysis
GBHPF
OTC
Company Description
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) is a dynamic company focused on Industrial Hemp and Biopharma. The Industrial Hemp division emphasizes environmental uses of hemp for construction and sustainable bio-energy sources, with a focus on developing Intellectual Property. The Health and Wellness Division acquires exclusive patents and IP, notably from Apollon Formularies plc. and B-Organic R&D Corp., specializing in cancer treatments from natural biologics, cannabinoids, terpenes, flavonoids, and mushroom extracts. These strategic alliances drive innovative ventures in the commercial biopharma sector.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$850.2K
Market Cap
34.9M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Global Hemp Group.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
March 24, 2028
Warrant exercise deadline
Frequently Asked Questions
What is the current stock price of Global Hemp Group (GBHPF)?
The current stock price of Global Hemp Group (GBHPF) is $0.0115 as of April 24, 2025.
What is the market cap of Global Hemp Group (GBHPF)?
The market cap of Global Hemp Group (GBHPF) is approximately 850.2K.
What is Global Hemp Group Inc. focused on?
Global Hemp Group Inc. is currently focused on Industrial Hemp and Biopharma, emphasizing environmental uses of hemp for construction and sustainable bio-energy sources, as well as acquiring exclusive patents and IP in the Health and Wellness Division.
What are the primary areas of interest for the Industrial Hemp division?
The primary focus of the Industrial Hemp division includes environmental uses of hemp for construction and sustainable bio-energy sources, contributing to a carbon-negative footprint, and developing Intellectual Property.
What strategic alliances has Global Hemp Group Inc. entered into?
Global Hemp Group Inc. has entered into strategic alliances with Apollon Formularies plc. and B-Organic R&D Corp., acquiring exclusive patents and IP specializing in cancer treatments from natural biologics, cannabinoids, terpenes, flavonoids, and mushroom extracts.
What drives Global Hemp Group Inc.'s innovative ventures in the biopharma sector?
Global Hemp Group Inc.'s strategic alliances with Apollon Formularies plc. and B-Organic R&D Corp. drive innovative ventures in the commercial biopharma sector, focusing on developing pre-clinically tested formulations for cancer treatments and enhancing solubility and bioavailability of various pharma ingredients.
What is the significance of the exclusive patents and IP acquired by Global Hemp Group Inc.?
The exclusive patents and IP acquired by Global Hemp Group Inc. from Apollon Formularies plc. and B-Organic R&D Corp. contribute to cutting-edge innovation in cancer treatments from natural biologics, cannabinoids, terpenes, flavonoids, and mushroom extracts, emphasizing the company's commitment to the commercial biopharma sector.